NCT02684123View on ClinicalTrials.gov

Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

September 15, 2017

Study Completion Date

September 15, 2017

Conditions

Alopecia Areata

Interventions

DRUG

Apremilast

Subjects will get drug or placebo

DRUG

Placebo

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02684123 - Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata | Biotech Hunter | Biotech Hunter